Voxel SA (Poland)

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: PLVOXEL00014
PLN
110.00
-1.4 (-1.26%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

High Management Efficiency with a high ROCE of 28.33%

 
2

High Debt Company with a Debt to Equity ratio (avg) at times

3

Healthy long term growth as Net Sales has grown by an annual rate of 17.22%

 
4

Positive results in Sep 25

5

With ROE of 26.79%, it has a fair valuation with a 4.89 Price to Book Value

6

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Hospital

stock-summary
Market cap

PLN 1,466 Million (Small Cap)

stock-summary
P/E

18.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

3.42%

stock-summary
Debt Equity

0.03

stock-summary
Return on Equity

25.52%

stock-summary
Price to Book

3.82

Revenue and Profits:
Net Sales:
143 Million
(Quarterly Results - Sep 2025)
Net Profit:
28 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.94%
0%
-8.94%
6 Months
-34.68%
0%
-34.68%
1 Year
-21.43%
0%
-21.43%
2 Years
17.27%
0%
17.27%
3 Years
168.29%
0%
168.29%
4 Years
180.61%
0%
180.61%
5 Years
141.23%
0%
141.23%

Voxel SA (Poland) for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
17.22%
EBIT Growth (5y)
40.41%
EBIT to Interest (avg)
9.52
Debt to EBITDA (avg)
0.48
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
1.30
Tax Ratio
18.12%
Dividend Payout Ratio
52.05%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
28.33%
ROE (avg)
24.52%

Valuation key factors

Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
4.89
EV to EBIT
13.91
EV to EBITDA
9.92
EV to Capital Employed
4.56
EV to Sales
3.17
PEG Ratio
2.24
Dividend Yield
2.88%
ROCE (Latest)
32.75%
ROE (Latest)
26.79%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 6.32% vs 5.16% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 9.84% vs 7.63% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "143.00",
          "val2": "134.50",
          "chgp": "6.32%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "49.70",
          "val2": "46.30",
          "chgp": "7.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.10",
          "val2": "2.40",
          "chgp": "-12.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.10",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "27.90",
          "val2": "25.40",
          "chgp": "9.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "249.50%",
          "val2": "255.90%",
          "chgp": "-0.64%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 19.71% vs 17.64% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 18.86% vs 48.11% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "507.80",
          "val2": "424.20",
          "chgp": "19.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "173.90",
          "val2": "149.30",
          "chgp": "16.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "9.50",
          "val2": "11.60",
          "chgp": "-18.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.60",
          "val2": "-0.20",
          "chgp": "3,900.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "97.70",
          "val2": "82.20",
          "chgp": "18.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "248.60%",
          "val2": "260.80%",
          "chgp": "-1.22%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoYstock-summary

Sep'25
Sep'24
Change(%)
Net Sales
143.00
134.50
6.32%
Operating Profit (PBDIT) excl Other Income
49.70
46.30
7.34%
Interest
2.10
2.40
-12.50%
Exceptional Items
0.00
-0.10
100.00%
Consolidate Net Profit
27.90
25.40
9.84%
Operating Profit Margin (Excl OI)
249.50%
255.90%
-0.64%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2025 is 6.32% vs 5.16% in Sep 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 9.84% vs 7.63% in Sep 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
507.80
424.20
19.71%
Operating Profit (PBDIT) excl Other Income
173.90
149.30
16.48%
Interest
9.50
11.60
-18.10%
Exceptional Items
7.60
-0.20
3,900.00%
Consolidate Net Profit
97.70
82.20
18.86%
Operating Profit Margin (Excl OI)
248.60%
260.80%
-1.22%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 19.71% vs 17.64% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 18.86% vs 48.11% in Dec 2023

stock-summaryCompany CV
About Voxel SA (Poland) stock-summary
stock-summary
Voxel SA (Poland)
Hospital
Voxel SA is a Poland-based company active in the healthcare sector. It provides services in the fields of diagnostic imaging, teleradiology and outsourcing, as well as information technology (IT) systems for hospitals and diagnostic centers. As of December 31, 2011, the Company operated two subsidiaries, 95.24%-owned Alteris SA and wholly owned CDO Sp. z o.o. On November 7, 2012, the Company sold its entire stake in Centrum Diagnostyki i Terapii Onkologicznej Sp. z o.o.
Company Coordinates stock-summary
Company Details
Ul. Wielicka 265 , KRAKOW None : 30-663
stock-summary
Tel: 48 32 6060501
stock-summary
Registrar Details